Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Editorial Group: Cochrane Kidney and Transplant Group
Published Online: 15 FEB 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Wang Y, Ivany JN, Perkovic V, Gallagher MP, Jardine MJ. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009631. DOI: 10.1002/14651858.CD009631.
- Publication Status: New
- Published Online: 15 FEB 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
This review aims to compare the prophylactic effect of different anticoagulant agents, preparations, doses and administration on the incidence of central venous haemodialysis catheter-related malfunction and sepsis in patients with ESKD.